The British pharmaceutical company said combinations for its Blenrep drug were evaluated in adults with relapsed or refractory multiple myeloma who have previously received at least one line of ...

The comeback story of belantamab mafodotin (Blenrep) hit a roadblock Thursday as the FDA's Oncologic Drugs Advisory Committee ...

The Senate Appropriations Committee has approved $27.1 billion in discretionary spending through the Fiscal Year 2026 Agriculture, Rural Development, Food and Drug Administration and Related Agencies ...

On a quest to bring its multiple myeloma antibody-drug conjugate (ADC) Blenrep back to the U.S. | Members of the FDA's Oncologic Drugs Advisory Committee voiced concerns with ocular toxicity side ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...

A group of independent advisors to the U.S. Food and Drug Administration (FDA) on Thursday voted against the approval of a combination drug regimen involving GSK’s (NYSE:GSK) blood cancer medicine ...

Health Secretary Robert F. Kennedy Jr. has repeatedly said that he wants to fix the way the government provides care to ...